Overview

A Study to Assess the Bioavailability of a New Tablet Formulation of Minzasolmin and the Effect of Food in Healthy Participants

Status:
COMPLETED
Trial end date:
2024-11-17
Target enrollment:
Participant gender:
Summary
The purpose of the study is to estimate the relative bioavailability of a new minzasolmin tablet formulation versus reference 'granules in capsule' formulation in healthy participants and to evaluate the effect of food with the new tablet formulation on the pharmacokinetics (PK) of minzasolmin.
Phase:
PHASE1
Details
Lead Sponsor:
UCB Biopharma SRL